Browse > Article

Short-term Effect of Botulinum Toxin Injection on the Surface EMG of Masticatory Muscles and Jaw Function  

Lee, Jeong-Yun (Department of Oral Medicine and Oral Diagnosis, School of Dentistry, Seoul National University)
Park, Hee-Kyung (Section of Forensic Dentistry, Department of Forensic Medicine, National Institute of Scientific Investigation)
Chung, Jin-Woo (Department of Oral Medicine and Oral Diagnosis, School of Dentistry, Seoul National University)
Publication Information
Journal of Oral Medicine and Pain / v.31, no.1, 2006 , pp. 69-77 More about this Journal
Abstract
Botulinum toxin injection has been used in the masticatory muscle area as an effective treatment method of various movement disorders and facial contouring, but its effects on jaw function have not been evaluated. The aims of this study were to evaluate the effects of botulinum toxin type A injection into the masseter muscle on the EMG activities of masseter and anterior temporal muscles, and the limitation of jaw function. Fourteen healthy subjects were recruited. Five subjects were injected with 80 units of botulinum toxin type A(Dysport, Ipsen, Wrexham, UK) into each side of masseter muscle, and nine subjects were injected with saline into the same site as the botulinum toxin group. The surface EMG activities at maximum voluntary contraction of masseter and anterior temporal muscles were recorded before, 1 week, 2 weeks, and 3 weeks after injection. Presence of jaw functional limitations in each subject was investigated using Korean version of Jaw Functional Limitation Scale(JFLS) questionnaire. The masseter muscle EMG was gradually decreased in the botulinum toxin group comparing with that of the control group(p<0.001), but the anterior temporal muscle EMG did not show significant changes. There was significant increases in the mastication (p<0.01), and global jaw limitation(p<0.05) subscales of JFLS at 1 week after injection, but no significant changes in the other subscales including opening, and verbal and emotional expression during the recording periods. Our results suggest that botulinum toxin injection into masseter muscle can affect modest limitation in mastication function at 1 week after injection but recovered to the baseline until 3 weeks after injection. The EMG activity of masseter muscle had been gradually decreased until 3 weeks after botulinum toxin injection but the anterior temporal muscle did not show any significant changes.
Keywords
Botulinum toxin; Masticatory muscle; EMG; Jaw functional limitation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001;248(Suppl 1):3-10   DOI   ScienceOn
2 Setler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain 2002;18(6 Suppl):S119-124   DOI
3 Simpson LL. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie 2000;82:943-953   DOI   ScienceOn
4 Ivanhoe CB, Lai JM, Francisco GE. Bruxism after brain injury: successful treatment with botulinum toxin-A. Arch Phys Med Rehabil 1997;78:1272-1273   DOI   ScienceOn
5 Van Zandijcke M, Marchau MM. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990;53:530
6 Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 1999;53:2102-2107   DOI   ScienceOn
7 Chauncey HH, Muench ME, Kapur KK, Wayler AH. The effect of the loss of teeth on diet and nutrition. Int Dent J 1984;34:98-104
8 Choe SW, Cho WI, Lee CK, Seo SJ. Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg 2005;31:502-507   DOI   ScienceOn
9 Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131:211-216   DOI
10 Rosenberg D, Kaplan S, Senie R, Badner V. Relationships among dental functional status, clinical dental measures, and generic health measures. J Dent Educ 1988;52:653-657
11 List T, Paulin G, Lundstrom I, Ohrbach R. Orofacial disorder diagnoses: Relationship to the jaw functional limitation scale. J Dent Res 2002;81 Special Issue A, 1024
12 Mandel L, Tharakan M. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report. J Oral Maxillofac Surg 1999;57:1017-1019   DOI
13 Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989;98:93-97
14 Arikan OK, Tan FU, Kendi T, Koc C. Use of botulinum toxin type a for the treatment of masseteric muscle hypertrophy. J Otolaryngol 2006;35:40-43   DOI   ScienceOn
15 Balash Y, Giladi N. Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 2004;11:361-370   DOI   ScienceOn
16 Stegenga B, de Bont LG, de Leeuw R, Boering G. Assessment of mandibular function impairment associated with temporomandibular joint osteoarthrosis and internal derangement. J Orofac Pain 1993;7:183-195
17 Ohrbach R, List T. Psychometric properties of the jaw functional limitation scale. J Dent Res 2002;81 Special Issue A, 1023
18 Carlsson GE. Masticatory efficiency: the effect of age, the loss of teeth and prosthetic rehabilitation. Int Dent J 1984;34:93-97
19 Zhang Y, Chung SC, Chung JW. Evaluation of jaw functional limitation in TMD Patients using a Korean version of Jaw Functional Limitation Scale (JFLS). Korean J of Oral Med 2004;29:297-304
20 Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain 2002;18(6 Suppl):S142-146   DOI
21 Pidcock FS, Wise JM, Christensen JR. Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report. J Oral Maxillofac Surg 2002;60:115-117   DOI   ScienceOn
22 Fasano A, Bentivoglio AR, Ialongo T, Soleti F, Evoli A. Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia. Neurology 2005;64:2155-2156   DOI
23 Dressler D, Saberi FA. Botulinum toxin: mechanisms of action. Eur Neurol 2005;53:3-9
24 Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 25;324:1186-1194